A randomised study comparing performance and safety of Eyestil Plus ® vs Vismed Multi ® in moderate-to-severe dry eye syndrome patients.

P J PisellaP GainB CochenerStephanie Baillif Laurent KodjikianC Creuzot-GarcherD TouboulM GonzalvezP GabissonS El AmaliD GalarretaJ Merayo LlovesAntonio Cano-OrtizR Ruiz MesaC CivialeM G MazzoneJ Montero

Published in: European journal of ophthalmology (2024)

This clinical investigation showed the non-inferiority of Eyestil Plus® compared to Vismed Multi® regarding performance and safety in a moderate-to-severe DED population.

Keyphrases

end stage renal disease
clinical trial
ejection fraction
newly diagnosed
high intensity
chronic kidney disease
early onset
peritoneal dialysis
randomized controlled trial
double blind
placebo controlled